Avingtrans Plc logo

Avingtrans Plc (AVG)

Market Closed
12 Aug, 15:30
LSE LSE
720. 00
GBX
0
0%
GBX
138.98M Market Cap
- P/E Ratio
7.2% Div Yield
67,318 Volume
- Eps
720 GBX
Previous Close
Add Transaction
Day Range
710 730
Year Range
424 730
Want to track AVG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

AVG closed today higher at 720 GBX, an increase of 0% from yesterday's close, completing a monthly decrease of -0.8264% or -6 GBX. Over the past 12 months, AVG stock gained 50%.
AVG is not paying dividends to its shareholders.
The last earnings report, released on Feb 24, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

AVG Chart

People also search for

HSP
Hargreaves Services Plc
804 GBX
+0.5%
SEE
Seeing Machines Limited
4.96 GBX
-2.7451%
SUP
Supreme Plc
143.58 GBX
+4.0435%
SOM
Somero Enterprises, Inc.
245 GBX
+2.0833%
CNS
China Steel Corporation Sponsored GDR
8.5 GBX
+3.0303%

Avingtrans Plc (AVG) FAQ

What is the stock price today?

The current price is 720.00 GBX.

On which exchange is it traded?

Avingtrans Plc is listed on LSE.

What is its stock symbol?

The ticker symbol is AVG.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 7.2%.

What is its market cap?

As of today, the market cap is 138.98M.

Has Avingtrans Plc ever had a stock split?

No, there has never been a stock split.

Avingtrans Plc Profile

Machinery Industry
Industrials Sector
Mr. Stephen McQuillan CEO
LSE Exchange
GB0009188797 ISIN
United Kingdom Country
941 Employees
28 May 2026 Last Dividend
- Last Split
- IPO Date

Overview

Avingtrans plc is a global company dedicated to providing engineered components, systems, and services to the energy, medical, and infrastructure sectors. With its broad operational scope, the company is divided into three key segments: Energy-EPM, Energy-PSRE, and Medical-MII. Originally known as Frank Usher Holding plc, Avingtrans adopted its current name in November 2000, signifying a strategic pivot towards its engineering and manufacturing core. Since its incorporation in 1985, Avingtrans has established itself as a reliable partner in its field, operating from its headquarters in Chatteris, United Kingdom. The company’s expertise lies in its ability to design, manufacture, integrate, and service a wide range of complex products that cater to the critical needs of its clientele across various industries.

Products and Services

Avingtrans plc offers a diverse portfolio of products and services designed to meet the sophisticated demands of the energy, medical, and infrastructure markets:

  • Electric Motors and Pumps: These are engineered to deliver high performance and reliability for various industrial applications, including those in harsh and demanding environments.
  • Steam Turbines and Gas Compressors: These components are essential for energy generation and processing, offering efficiency and durability for long-term operations.
  • Pressure Vessels, Blast Doors, Containers, and Skidded Systems: Avingtrans designs and manufactures these products to meet the highest standards of safety and quality, catering to the specific needs of its customers in the energy sector.
  • Medical Diagnostic Equipment: The company is involved in the production of advanced equipment used in the medical field, supporting the diagnosis and treatment of various conditions with cutting-edge technology.
  • High Performance Pressure and Vacuum Vessels, Composite Materials for Research Organizations: Avingtrans plays a crucial role in the provision of essential equipment for scientific research, including vessels and materials designed for high-pressure and vacuum applications.
  • Superconducting Magnets and Helium-Free Cryogenic Systems: These are crucial for magnetic resonance imaging (MRI) and nuclear magnetic resonance (NMR), offering innovative solutions that enhance the capabilities of medical and research institutions.

Contact Information

Address: Chatteris Business Park
Phone: 44 1354 692 391